Information on the Total Number of Voting Rights (Denominator) Following the Completion of the LDA Capital Increase

Liege, Belgium, 30 June 2022 – 17:45 CEST – In accordance with article 15 of the Belgian Act of 2 May 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, Mithra Pharmaceuticals SA (the “Company” or “Mithra”) announces the below information, following the issuance of 625,000 new shares today for a total amount of EUR 4,133,933 following the Put Option Notice issued on 13 May, 2022 in the framework of LDA capital commitment agreement entered into April 2020 and extended in April 2022.